For the year ending 2025-12-31, IBRX has $501,898K in assets. $1,001,472K in debts. $88,334K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 88,334 | 143,428 | 265,453 | 104,641 |
| Marketable securities | 154,484 | 6,381 | 1,009 | 2,543 |
| Accounts receivable, net | 42,571 | 2,360 | - | - |
| Inventories | 910 | 8,272 | - | - |
| Due from related parties | - | 293 | 2,019 | 1,890 |
| Due from related parties-Related Party | 46 | - | - | - |
| Prepaid expenses and other current assets-Nonrelated Party | 27,761 | - | - | - |
| Prepaid expenses and other current assets (including amounts with related parties) | - | 23,852 | 25,603 | 31,503 |
| Prepaid expenses and other current assets-Related Party | 769 | - | - | - |
| Total current assets | 314,875 | 184,586 | 294,084 | 140,577 |
| Marketable securities, noncurrent | - | 0 | 891 | 840 |
| Property, plant and equipment, net | 114,264 | 137,094 | 146,082 | 143,659 |
| Off Market Favorable Lease | - | - | - | 20,398 |
| Organized Workforce | - | - | - | 831 |
| Finite Lived Intangible Assets Gross | - | - | - | 21,229 |
| Net carrying amount | - | - | - | 1,390 |
| Gross carrying amount | - | - | - | 22,619 |
| Accumulated amortization | - | - | - | 1,935 |
| Impairment | - | - | - | 681 |
| Goodwill and intangible assets, net | 13,953 | 15,933 | - | - |
| Intangible assets, net | - | - | 17,093 | 20,003 |
| Long-term inventories | 13,508 | - | - | - |
| Convertible note receivable | 7,380 | 7,130 | 6,879 | 6,629 |
| Operating lease right-of-use assets, net-Nonrelated Party | 19,808 | - | - | - |
| Operating lease right-of-use assets, net-Related Party | 13,202 | - | - | - |
| Operating lease right-of-use assets, net (including amounts with related parties) | - | 33,363 | 36,543 | 45,788 |
| Other assets-Nonrelated Party | 4,530 | - | - | - |
| Other assets (including amounts with related parties) | - | 4,827 | 2,880 | 4,860 |
| Other assets-Related Party | 378 | - | - | - |
| Total assets | 501,898 | 382,933 | 504,452 | 362,356 |
| Accrued expenses and other liabilities-Nonrelated Party | 6,978 | 6,725 | 9,195 | - |
| Accounts payable | - | - | - | 21,016 |
| Related-party notes payable | 46,838 | 40,580 | 42,708 | 41,825 |
| Related-party promissory notes, net of discounts and deferred issuance costs (note10) | - | - | 0 | - |
| Due to related parties-Nonrelated Party | 4,291 | - | - | - |
| Related-party promissory notes, net of discounts and deferred issuance costs-Promissory Notes Payable | - | - | - | 431,901 |
| Due to related parties-Related Party | 3,244 | - | - | - |
| Due to related parties | - | - | - | 3,469 |
| Accrued expenses and other liabilities-Related Party | 403 | 173 | 1,136 | - |
| Operating lease liabilities (including amounts with related parties) | - | 7,466 | 5,244 | 2,650 |
| Related-party convertible notes payable, less current portion | 61,754 | 54,944 | 58,283 | 500,861 |
| Related-party nonconvertible note, net of discount (note 12) | - | 0 | 104,586 | - |
| Related-party convertible notes and accrued interest, net of discount (note 12) | - | 0 | 576,951 | - |
| Related-party convertible note payable, at fair value (note7 and note12) | - | 461,877 | - | - |
| Related-party convertible note payable, at fair value-Related Party | 477,093 | - | - | - |
| Revenue interest liability | 324,615 | 284,404 | 155,415 | - |
| Operating lease liabilities, less current portion-Nonrelated Party | 19,732 | - | - | - |
| Related-party promissory notes, less current portion (note 9)-Promissory Notes Payable | - | - | - | 0 |
| Operating lease liabilities, less current portion-Related Party | 13,715 | - | - | - |
| Related-party promissory notes, less current portion (note 9)-Convertible Notes Payable | - | - | - | 241,271 |
| Derivative liabilities | 19,722 | 25,800 | 35,333 | - |
| Operating lease liabilities, less current portion (including amounts with related parties) | - | 34,823 | 39,942 | 47,951 |
| Warrant liabilities (note16) and (note23) | 84,417 | 8,575 | 118,770 | 21,636 |
| Other liabilities | 424 | 639 | 1,109 | 457 |
| Total liabilities | 1,001,472 | 871,062 | 1,090,389 | 812,176 |
| Common stock, 0.0001 par value 1,650,000,000 and 1,350,000,000 shares authorized as of december31, 2025 and 2024, respectively 1,011,800,008 and 852,904,340 shares issued and outstanding as of december31, 2025 and 2024, respectively excluding treasury stock, 163,800 shares outstanding as of december31, 2025 and 2024 | 101 | 85 | 67 | 42 |
| Additional paid-in capital | 3,197,120 | 2,884,867 | 2,374,620 | 1,930,936 |
| Accumulated deficit | -3,726,646 | -3,375,248 | -2,961,684 | -2,378,488 |
| Accumulated other comprehensive income | 28,956 | 1,198 | 10 | 183 |
| Total immunitybio stockholders deficit | -500,469 | -489,098 | -586,987 | -447,327 |
| Noncontrolling interests | 895 | 969 | 1,050 | -2,493 |
| Total stockholders deficit | -499,574 | -488,129 | -585,937 | -449,820 |
| Total liabilities and stockholders deficit | 501,898 | 382,933 | 504,452 | 362,356 |
ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX)